4DMedical Limited (ASX:4DX)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2015
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Dec 31, 2015
Medical Technology R & D of Lung Function Analysis	5.85M	3.75M	718.58K	1.05M	216.98K
Medical Technology R & D of Lung Function Analysis Growth	55.91%	422.45%	-31.84%	385.90%	-82.40%
Total	5.85M	3.75M	718.58K	1.05M	216.98K
Total Growth	55.91%	422.45%	-31.84%	385.90%	-82.40%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2015
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Dec 31, 2015
United States of America	5.73M	2.93M	175.87K	954.00K	116.98K
United States of America Growth	95.60%	1565.74%	-81.56%	715.54%	259.92%
Australia	123.20K	824.70K	542.71K	100.30K	100.00K
Australia Growth	-85.06%	51.96%	441.09%	0.30%	-91.67%
Total	5.85M	3.75M	718.58K	1.05M	216.98K
Total Growth	55.91%	422.45%	-31.84%	385.90%	-82.40%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 16, 2026

Data Sources Report a data error